ArticleFrontiers in pharmacology2021

Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?

Yuqian Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.